Baraclude recommended as primary choice of B hepatitis therapy.

A revised U. S. therapeutic guideline for B viral hepatitis infection treatment has been introduced into Korea for the first time.

Prof. Emmet B. Keeffe of the medical center of Stanford University who established the therapeutic guideline for the chronic B viral hepatitis infection addressed his guideline during the launching occasion of Baraclude symposium held by BMS Korea at Jamsil on Fe...